The present study uncovered a rare co-occurrence of KRAS (G13D) and BRAF (V600E) alterations in CRC, highlighting tumor heterogeneity and challenging the assumption that these mutations are mutually exclusive within the studied ethnicity. Here, BRAF is linked to neoplasm.